These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17640727)

  • 1. Targeting of opioid-producing leukocytes for pain control.
    Machelska H
    Neuropeptides; 2007 Dec; 41(6):355-63. PubMed ID: 17640727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and sensory nerves.
    Stein C; Zöllner C
    Handb Exp Pharmacol; 2009; (194):495-518. PubMed ID: 19655116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocytes in the regulation of pain and analgesia.
    Rittner HL; Machelska H; Stein C
    J Leukoc Biol; 2005 Dec; 78(6):1215-22. PubMed ID: 16204636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral mechanisms of opioid analgesia.
    Stein C; Lang LJ
    Curr Opin Pharmacol; 2009 Feb; 9(1):3-8. PubMed ID: 19157985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally acting opioids and clinical implications for pain control.
    Sehgal N; Smith HS; Manchikanti L
    Pain Physician; 2011; 14(3):249-58. PubMed ID: 21587328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte-derived opioid peptides and inhibition of pain.
    Machelska H; Stein C
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):90-7. PubMed ID: 18040794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain.
    Mousa SA; Shaqura M; Brendl U; Al-Khrasani M; Fürst S; Schäfer M
    Brain Behav Immun; 2010 Nov; 24(8):1310-23. PubMed ID: 20600813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling pain by influencing neurogenic pathways.
    Puehler W; Stein C
    Rheum Dis Clin North Am; 2005 Feb; 31(1):103-13, ix. PubMed ID: 15639058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications.
    Hua S; Cabot PJ
    Trends Pharmacol Sci; 2010 Sep; 31(9):427-33. PubMed ID: 20591509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception.
    Rittner HL; Lux C; Labuz D; Mousa SA; Schäfer M; Stein C; Brack A
    Anesthesiology; 2007 Dec; 107(6):1009-17. PubMed ID: 18043070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects.
    Busch-Dienstfertig M; Stein C
    Brain Behav Immun; 2010 Jul; 24(5):683-94. PubMed ID: 19879349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual peripheral actions of immune cells in neuropathic pain.
    Machelska H
    Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):11-24. PubMed ID: 21234811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia.
    Rittner HL; Stein C
    Eur J Pain; 2005 Apr; 9(2):109-12. PubMed ID: 15737796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy.
    Stein C; Machelska H
    Pharmacol Rev; 2011 Dec; 63(4):860-81. PubMed ID: 21969325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.
    Brack A; Rittner HL; Machelska H; Shaqura M; Mousa SA; Labuz D; Zöllner C; Schäfer M; Stein C
    Pain; 2004 Mar; 108(1-2):67-75. PubMed ID: 15109509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain.
    Machelska H; Brack A; Mousa SA; Schopohl JK; Rittner HL; Schäfer M; Stein C
    Br J Pharmacol; 2004 Jun; 142(4):772-80. PubMed ID: 15159283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte opioid receptors mediate analgesia via Ca(2+)-regulated release of opioid peptides.
    Celik MÖ; Labuz D; Henning K; Busch-Dienstfertig M; Gaveriaux-Ruff C; Kieffer BL; Zimmer A; Machelska H
    Brain Behav Immun; 2016 Oct; 57():227-242. PubMed ID: 27139929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells.
    Rittner HL; Labuz D; Schaefer M; Mousa SA; Schulz S; Schäfer M; Stein C; Brack A
    FASEB J; 2006 Dec; 20(14):2627-9. PubMed ID: 17060402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain control in inflammation governed by selectins.
    Machelska H; Cabot PJ; Mousa SA; Zhang Q; Stein C
    Nat Med; 1998 Dec; 4(12):1425-8. PubMed ID: 9846582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attacking pain at its source: new perspectives on opioids.
    Stein C; Schäfer M; Machelska H
    Nat Med; 2003 Aug; 9(8):1003-8. PubMed ID: 12894165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.